Showing results (331-340 of 928) with videos related to

Sort By:
Pageof 93
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2014
Evaluation of opioid modulation in major depressive disorderElliot Ehrich, Ryan Turncliff, Yangchun Du, et al.
Neuropsychiatric Disease and Treatment|January 19, 2018
Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studiesEmmanuelle Weiller, Catherine Weiss, Christopher P Watling, et al.
International Journal of Psychiatry in Medicine|July 25, 2007
Major depressive disorder with anger attacks and cardiovascular risk factorsRenerio Fraguas, Dan V Iosifescu, Bettina Bankier, et al.
International Clinical Psychopharmacology|February 25, 2005
The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatientsAmy Farabaugh, David Mischoulon, Maurizio Fava, et al.
Psychiatry Research|May 26, 2004
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorderGeorge I Papakostas, Timothy Petersen, Megan E Hughes, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 6, 2002
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depressionJonathan E Alpert, David Mischoulon, Grace E F Rubenstein, et al.
The Journal of Clinical Psychiatry|May 11, 2006
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional researchAlan F Schatzberg, Pierre Blier, Pedro L Delgado, et al.
Psychiatric Services (Washington, D.C.)|November 3, 2009
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depressionBradley N Gaynes, Diane Warden, Madhukar H Trivedi, et al.
Pageof 93